Recovery99.2% verified
Move cursor to rotate · 3D render
Recovery · Compound
CJC-1295 (DAC)
CAS
863288-34-0
Dose
5mg per vial
Formula
C₁₅₂H₂₅₂N₄₄O₄₂
MW
3367.87 g/mol
Batch
PX-2026-0146
Purity
99.2%
GHRH analog with drug-affinity-complex modification extending half-life into a multi-day window.
Per vial · CAD
CAD $69
Selected
5mg per vial
Lyophilized · ambient-stable · In stock
Batch PX-2026-0146 →Research use only. Not for diagnostic, therapeutic, or human-consumption use.
Buying in volume? US and UK wholesale handled by direct contact — custom rates by monthly order volume.
Apply to the wholesale program Production COA
Per batch
Verification
3rd party
Form
Lyophilized
Current batch
The chromatogram for this vial.
Batch PX-2026-0146 · HPLC trace
CJC-1295 (DAC)
Purity
99.2%
Produced
2026-04-10
Verified
2026-04-14
Signed by Independent third-party lab · 2026-04-14Hover the peaks to inspect retention times
Overview
About the compound.
CJC-1295 is a 30-amino-acid GHRH analog modified with a drug-affinity-complex (DAC) linkage that binds covalently to serum albumin, extending its half-life into a multi-day range. Frequently studied alongside Ipamorelin to elevate baseline GH while preserving pulsatility.
Research contexts
GHRH analog researchLong-acting peptide pharmacokineticsGH-axis modeling
Batch history
Every batch we’ve ever sent out.
Adjacent research
Compounds that pair with CJC-1295 (DAC).
Metabolic99.1% verified
CAS 2381089-83-2
C₂₁₄H₃₃₃N₅₀O₆₅
GLP-3 (Retatrutide)
5mg per vial · Batch PX-2026-0142
From CAD $129
per vial · CAD
Longevity99.0% verified
CAS 53-84-9
C₂₁H₂₇N₇O₁₄P₂
NAD+
500mg per vial · Batch PX-2026-0138
CAD $149
per vial · CAD
Recovery98.9% verified
CAS Blend
BPC-157 · TB-500 · GHK-Cu · KPV
KLOW
50mg blend per vial · Batch PX-2026-0133
CAD $219
per vial · CAD
5mg per vial
CAD $69